Manufacturer record
Aspen Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Aspen Lifesciences (Punjab) were declared Not of Standard Quality between December 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: A20718, Drotaverine Hydrocloride suspension (exp Mar 2027). Drug Testing Laboratory, Madurai-19 (state lab) found it not of standard quality: content - Drotaverine Hydrochloride. Listed in the September 2026 alert.
Records by type
2 records linked to Aspen Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Drotaverine Hydrocloride suspension | Batch A20718Mfg Apr 2025 · Exp Mar 2027 | content - Drotaverine HydrochlorideOther | Drug Testing Laboratory, Madurai-19State lab | Sep 2026 |
| Ambroxol Hydrochloride, Guaiphenesin and Levosalbutamol Syrup Corun-LA Junior Syrup | Batch A20497BMfg Mar 2025 · Exp Feb 2027 | The sample does not conform to claim as per Manufacturer's Specification with respect to Assay of Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.